(Q40993198)

25 September 2017

Effects of arginine vasopressin and oxytocin on glucagon release from clonal alpha-cell line In-R1-G9: involvement of V1b receptors (English)

1 reference

25 September 2017

0 references

1 reference

1 reference

Yibchok-anun S

1

1 reference

PubMed ID

9825765

25 September 2017

Hsu WH

series ordinal

2

1 reference

PubMed ID

9825765

25 September 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

25 September 2017

1 reference

25 September 2017

63

1 reference

25 September 2017

21

1 reference

25 September 2017

1871-1878

1 reference

Oxytocin and vasopressin are present in human and rat pancreas

25 September 2017

2 references

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900463-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900463-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Modulation of insulin and glucagon secretion from the perfused rat pancreas by the neurohypophysial hormones and by desamino-D-arginine vasopressin (DDAVP)

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900463-9

The influence of vasopressin and related peptides on glycogen phosphorylase activity and phosphatidylinositol metabolism in hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900463-9

Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900463-9

Vasopressin receptor mediated contraction and [3H]inositol metabolism in rat tail artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900463-9

Signal transduction of V1-vascular vasopressin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900463-9

Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary corticotropin (ACTH) release are mediated by a novel type of receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900463-9

Novel Ligand Specificity of Pituitary Vasopressin Receptors in the Rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900463-9

Tachykinins activate nonselective cation currents in canine colonic myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900463-9

Lysine vasopressin-induced increases in porcine myometrial contractility and intracellular Ca2+ concentrations of myometrial cells: involvement of oxytocin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900463-9

A potent new synthetic analog of vasopressin with relative agonist specificity for the pituitary.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900463-9

Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900463-9

The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900463-9

C-terminal deletions in agonistic and antagonistic analogues of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900463-9

Novel approach to the design of synthetic radioiodinated linear V1A receptor antagonists of vasopressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900463-9

Molecular cloning and characterization of rat V1b vasopressin receptor: evidence for its expression in extra-pituitary tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900463-9

10.1016/S0024-3205(98)00463-9

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference

PubMed ID

9825765